NovaVive Inc. - Canine

Home
Canada
Napanee, ON
NovaVive Inc. - Canine

NovaVive offers a regulator-approved immunotherapy for canine mammary cancer in the USA and Canada. NovaVive Inc.

is an animal health immunobiology company with a regulator-approved canine cancer product available to veterinarians in CA and the US.

07/08/2025

Cody sadly lost his battle with cancer. However, we were glad to be able to offer support for 16-and-a-half months after he started our therapy.

Immunocidin immunotherapy is regulator-approved in the USA and Canada for the treatment of canine mammary cancer, but it is being used experimentally to treat a variety of other cancer types, including osteosarcoma.

Immunocidin has also proven helpful as a palliative (end-of-life) support for dogs when treatment is no longer an option.

Learn more at NovaVive.ca/products or ask your veterinarian to contact us.

07/03/2025

Immunocidin is our immunotherapy for canine cancer. Visit NovaVive.ca/products to learn more.

07/02/2025

Seeing our beloved pets reach the end of their lives is difficult. Often, there are no further treatment options and we must face losing them.

Immunocidin immunotherapy has been used as a palliative treatment to help pets stay comfortable. Ask your veterinarian about Immunocidin or visit NovaVive.ca/products for more information.

06/24/2025

Immunocidin® immunotherapy has proven safe and effective as an intratumoral treatment for canine mammary cancer. Further research has demonstrated that it can also be safely administered by IV injection.

Immunocidin is approved by regulators in the USA and Canada. Research is ongoing with this product in various tumor types using different administration methods.

Visit NovaVive.ca/products for more information.

06/18/2025

Immunocidin® immunotherapy is approved in the USA and Canada for the treatment of canine mammary cancer, but it is being used experimentally to treat a variety of other cancer types.

Immunocidin has also proven helpful as a palliative (end-of-life) support for dogs when treatment is no longer an option.

It is safe to use in all veterinary clinics.

Learn more at NovaVive.ca/products or ask your veterinarian to contact us.

06/11/2025

Please enjoy reading the latest quarterly business update newsletter from NovaVive - Volume 11, Issue 2 - https://tinyurl.com/58sf5srk.

For further information, visit our website – www.NovaVive.ca.

06/10/2025

Scarlet sadly lost her battle with cancer. However, we were glad to be able to offer support for more than four years after her cancer diagnosis.

Our Immunocidin immunotherapy is regulator-approved in the USA and Canada for the treatment of canine mammary cancer, but it is being used experimentally to treat a variety of other cancer types, including osteosarcoma.

Immunocidin has also proven helpful as a palliative (end-of-life) support for dogs when treatment is no longer an option.

Learn more at NovaVive.ca/products or ask your veterinarian to contact us.

06/03/2025

Murphy sadly lost his battle with cancer. However, we were glad to be able to offer support in the last several weeks of his life.

Our Immunocidin immunotherapy is regulator-approved in the USA and Canada for the treatment of canine mammary cancer, but it is being used experimentally to treat a variety of other cancer types.

Immunocidin has also proven helpful as a palliative (end-of-life) support for dogs when treatment is no longer an option.

Learn more at NovaVive.ca/products or ask your veterinarian to contact us.

05/27/2025

Immunocidin immunotherapy is approved by regulators in the USA and Canada for the treatment of canine mammary cancer.

NovaVive continues to explore other cancers for which Immunocidin may be effective. One of these is osteosarcoma (bone cancer).

Learn more about Immunocidin research at http://novavive.ca/canine-research.

05/21/2025

Immunocidin is approved by regulators in the USA and Canada for the treatment of canine mammary cancer and is undergoing further research in other tumor types including transitional cell carcinoma.

We’re pleased to help dogs like Kiska live their best lives despite a cancer diagnosis.

Visit NovaVive.ca/products to learn more.

05/13/2025

Immunocidin is approved by regulators in the USA and Canada for the treatment of canine mammary cancer and is undergoing further research in other tumor types like transitional cell carcinoma.

We’re pleased to help dogs like Hana live their best lives despite a cancer diagnosis.

Visit NovaVive.ca/products to learn more.

05/06/2025

Immunocidin® immunotherapy works by stimulating direct and indirect anticancer activity in the dog.

The product is approved in the USA and Canada for treating canine mammary cancer and research is ongoing in other tumor types.

Visit NovaVive.ca/products to learn more.

Address

Napanee, ON

Website

http://www.NovaVive.ca/

Alerts

Be the first to know and let us send you an email when NovaVive Inc. - Canine posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to NovaVive Inc. - Canine: